Vivos Therapeutics, Inc. (VVOS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 11:40AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 7.72M |
| Enterprise Value | 8.08M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.23 |
| Price/Book (mrq) | 18.79 |
| Enterprise Value/Revenue | 0.59 |
| Enterprise Value/EBITDA | -0.48 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 7.90 |
| 52-Week Change 3 | -69.53% |
| S&P500 52-Week Change 3 | 24.19% |
| 52 Week High 3 | 48.7900 |
| 52 Week Low 3 | 2.3700 |
| 50-Day Moving Average 3 | 4.0057 |
| 200-Day Moving Average 3 | 6.6898 |
Share Statistics
| Avg Vol (3 month) 3 | 192.73k |
| Avg Vol (10 day) 3 | 49.99k |
| Shares Outstanding 5 | 2.98M |
| Implied Shares Outstanding 6 | 2.98M |
| Float 8 | 2M |
| % Held by Insiders 1 | 6.77% |
| % Held by Institutions 1 | 13.10% |
| Shares Short (Apr 15, 2024) 4 | 191.08k |
| Short Ratio (Apr 15, 2024) 4 | 0.5 |
| Short % of Float (Apr 15, 2024) 4 | 9.27% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 6.41% |
| Shares Short (prior month Mar 15, 2024) 4 | 26.18k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:25 |
| Last Split Date 3 | Oct 27, 2023 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -98.42% |
| Operating Margin (ttm) | -127.25% |
Management Effectiveness
| Return on Assets (ttm) | -88.43% |
| Return on Equity (ttm) | -521.22% |
Income Statement
| Revenue (ttm) | 13.8M |
| Revenue Per Share (ttm) | 11.32 |
| Quarterly Revenue Growth (yoy) | -17.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -16.68M |
| Net Income Avi to Common (ttm) | -13.58M |
| Diluted EPS (ttm) | -11.1400 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.64M |
| Total Cash Per Share (mrq) | 0.6 |
| Total Debt (mrq) | 2M |
| Total Debt/Equity (mrq) | 485.40% |
| Current Ratio (mrq) | 0.34 |
| Book Value Per Share (mrq) | 0.22 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11.95M |
| Levered Free Cash Flow (ttm) | -7.69M |
© 2024 Yahoo. All rights reserved.